Literature DB >> 25387000

Von Willebrand factor is elevated in individuals infected with Sudan virus and is associated with adverse clinical outcomes.

Anita K McElroy1, Bobbie R Erickson, Timothy D Flietstra, Pierre E Rollin, Jonathan S Towner, Stuart T Nichol, Christina F Spiropoulou.   

Abstract

Sudan virus (SUDV) is a member of the Filoviridae family that has been associated with sporadic outbreaks of human disease in sub-Saharan Africa. The filoviruses are notable for the high frequencies with which they cause both hemorrhagic manifestations and death in infected individuals. Recently, we reported an extensive biomarker analysis of patient specimens from the Gulu SUDV outbreak. In that study, we found evidence of endothelial dysfunction and alterations of factors important to the coagulation pathways. The complex intersection between the endothelium, coagulation, and immunity is further explored in this study where we examine several additional biomarkers using the same patient specimens. We report that von Willebrand factor (vWF), a protein that promotes platelet adhesion to the injured endothelium, is elevated in SUDV-infected individuals compared to normally reported values in healthy individuals. Furthermore, vWF is associated with a fatal outcome in SUDV-infected pediatric patients. In addition, we find that vWF is elevated in individuals who have hemorrhagic manifestations of disease, suggesting excessive thrombosis in these patients.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25387000      PMCID: PMC4287115          DOI: 10.1089/vim.2014.0072

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  15 in total

1.  Plasma ADAMTS13, von Willebrand factor (VWF) and VWF propeptide profiles in patients with DIC and related diseases.

Authors:  Koji Habe; Hideo Wada; Naomi Ito-Habe; Tsuyoshi Hatada; Takeshi Matsumoto; Kohshi Ohishi; Kazuo Maruyama; Hiroshi Imai; Hitoshi Mizutani; Tsutomu Nobori
Journal:  Thromb Res       Date:  2011-11-08       Impact factor: 3.944

Review 2.  Platelets as immune cells in infectious diseases.

Authors:  Cornelia Speth; Jürgen Löffler; Sven Krappmann; Cornelia Lass-Flörl; Günter Rambach
Journal:  Future Microbiol       Date:  2013-11       Impact factor: 3.165

Review 3.  von Willebrand factor: a marker of endothelial damage?

Authors:  P M Mannucci
Journal:  Arterioscler Thromb Vasc Biol       Date:  1998-09       Impact factor: 8.311

4.  Unexpected Ebola virus in a tertiary setting: clinical and epidemiologic aspects.

Authors:  G A Richards; S Murphy; R Jobson; M Mer; C Zinman; R Taylor; R Swanepoel; A Duse; G Sharp; I C De La Rey; C Kassianides
Journal:  Crit Care Med       Date:  2000-01       Impact factor: 7.598

5.  Platelet ligands and ADAMTS13 during Puumala hantavirus infection and associated thrombocytopenia.

Authors:  Outi Laine; Satu Mäkelä; Jukka Mustonen; Mika Helminen; Antti Vaheri; Riitta Lassila; Lotta Joutsi-Korhonen
Journal:  Blood Coagul Fibrinolysis       Date:  2011-09       Impact factor: 1.276

6.  von Willebrand factor-mediated platelet adhesion is critical for deep vein thrombosis in mouse models.

Authors:  Alexander Brill; Tobias A Fuchs; Anil K Chauhan; Janie J Yang; Simon F De Meyer; Maria Köllnberger; Thomas W Wakefield; Bernhard Lämmle; Steffen Massberg; Denisa D Wagner
Journal:  Blood       Date:  2010-10-19       Impact factor: 22.113

7.  Ebola hemorrhagic Fever: novel biomarker correlates of clinical outcome.

Authors:  Anita K McElroy; Bobbie R Erickson; Timothy D Flietstra; Pierre E Rollin; Stuart T Nichol; Jonathan S Towner; Christina F Spiropoulou
Journal:  J Infect Dis       Date:  2014-02-12       Impact factor: 5.226

8.  Activation of endothelial cells, coagulation and fibrinolysis in children with Dengue virus infection.

Authors:  Darintr Sosothikul; Panya Seksarn; Sureeporn Pongsewalak; Usa Thisyakorn; Jeanne Lusher
Journal:  Thromb Haemost       Date:  2007-04       Impact factor: 5.249

9.  Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology.

Authors:  M Levi; C H Toh; J Thachil; H G Watson
Journal:  Br J Haematol       Date:  2009-02-12       Impact factor: 6.998

10.  Biological determinants of serum ICAM-1, E-selectin, P-selectin and L-selectin levels in healthy subjects: the Stanislas study.

Authors:  Anne Ponthieux; Bernard Herbeth; Suzanne Droesch; Nadia Haddy; Daniel Lambert; Sophie Visvikis
Journal:  Atherosclerosis       Date:  2004-02       Impact factor: 5.162

View more
  9 in total

1.  Dengue Virus NS1 Exposure Affects von Willebrand Factor Profile and Platelet Adhesion Properties of Cultured Vascular Endothelial Cells.

Authors:  Nitali Tadkalkar; Sharda Prasad; Shobha Gangodkar; Kanjaksha Ghosh; Atanu Basu
Journal:  Indian J Hematol Blood Transfus       Date:  2018-12-06       Impact factor: 0.900

2.  Comparison of the Pathogenesis of the Angola and Ravn Strains of Marburg Virus in the Outbred Guinea Pig Model.

Authors:  Robert W Cross; Karla A Fenton; Joan B Geisbert; Hideki Ebihara; Chad E Mire; Thomas W Geisbert
Journal:  J Infect Dis       Date:  2015-06-19       Impact factor: 5.226

3.  Von Willebrand factor protects against acute CCl4-induced hepatotoxicity through phospho-p38 MAPK signaling pathway inhibition.

Authors:  Hai-Jian Sun; Jian Chen; Hao Zhang; Bing Ni; Jennifer C van Velkinburgh; Yao Liu; Yu-Zhang Wu; Xia Yang
Journal:  Immunol Res       Date:  2017-10       Impact factor: 2.829

Review 4.  Post-exposure treatments for Ebola and Marburg virus infections.

Authors:  Robert W Cross; Chad E Mire; Heinz Feldmann; Thomas W Geisbert
Journal:  Nat Rev Drug Discov       Date:  2018-01-29       Impact factor: 84.694

Review 5.  Platelets in Viral Infections - Brave Soldiers or Trojan Horses.

Authors:  Waltraud C Schrottmaier; Anna Schmuckenschlager; Anita Pirabe; Alice Assinger
Journal:  Front Immunol       Date:  2022-03-28       Impact factor: 7.561

6.  Solving the Measurement Problem and then Steppin' Out over the Line Riding the Rarest Italian: Crossing the Streams to Retrieve Stable Bioactivity in Majorana Bound States of Dialy zed Human Platelet Lysates.

Authors:  Mark Roedersheimer
Journal:  Open Neurol J       Date:  2015-06-26

7.  Characterization of the plasma proteome of nonhuman primates during Ebola virus disease or melioidosis: a host response comparison.

Authors:  Michael D Ward; Ernst E Brueggemann; Tara Kenny; Raven E Reitstetter; Christopher R Mahone; Sylvia Trevino; Kelly Wetzel; Ginger C Donnelly; Cary Retterer; Robert B Norgren; Rekha G Panchal; Travis K Warren; Sina Bavari; Lisa H Cazares
Journal:  Clin Proteomics       Date:  2019-02-07       Impact factor: 3.988

Review 8.  Ebola Virus Disease in Humans: Pathophysiology and Immunity.

Authors:  César Muñoz-Fontela; Anita K McElroy
Journal:  Curr Top Microbiol Immunol       Date:  2017       Impact factor: 4.291

9.  Kinetics of Soluble Mediators of the Host Response in Ebola Virus Disease.

Authors:  Romy Kerber; Ralf Krumkamp; Misa Korva; Toni Rieger; Stephanie Wurr; Sophie Duraffour; Lisa Oestereich; Martin Gabriel; Daouda Sissoko; Xavier Anglaret; Denis Malvy; Jürgen May; Tatjana Avšic Županc; César Muñoz-Fontela; Stephan Günther
Journal:  J Infect Dis       Date:  2018-11-22       Impact factor: 5.226

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.